Moreover, when we focused on GBM samples, the analysis of the TGCA RNASeq dataset revealed that TLR4 expression was higher in the MES subtype, with the poorest outcome when compared to PN and CS subtypes. The gene discussed is TLR4; the disease is glioblastoma.